Søgeresultater - Tommy Förnander
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen af Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy� Fornander, Olle Stål, Lambert Skoog, Jonas Bergh, Bo Nordenskjöld
Udgivet 2010Artigo -
10
-
11
Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study af Voralak Vichapat, Hans Garmo, Marit Holmqvist, Göran Liljegren, Fredrik Wärnberg, Mats Lambe, Tommy� Fornander, Jan Adolfsson, Margreet Lüchtenborg, Lars Holmberg
Udgivet 2012Artigo -
12
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patien... af Elin Karlsson, Gizeh Pérez‐Tenorio, Risul Amin, Josefine Bostner, Lambert Skoog, Tommy� Fornander, Dennis C. Sgroi, Bo Nordenskjöld, Anna‐Lotta Hallbeck, Olle Stål
Udgivet 2013Artigo -
13
Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer af A. Hackshaw, Michael Baum, Tommy� Fornander, Bo Nordenskjöld, Antonio Nicolucci, Kathryn Monson, Sharon Forsyth, Krystyna Reczko, Unn‐Britt Johansson, Helena Fohlin, Umberto Valentini, R Sainsbury
Udgivet 2009Artigo -
14
-
15
Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence af Yi Zhang, Catherine A. Schnabel, Brock E. Schroeder, Piiha-Lotta Jerevall, Rachel C. Jankowitz, Tommy� Fornander, Olle Stål, Adam Brufsky, Dennis C. Sgroi, Mark G. Erlander
Udgivet 2013Artigo -
16
Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial af P-L Jerevall, X-J Ma, Huan Li, Ranelle Salunga, Nicole C. Kesty, Mark G. Erlander, Dennis C. Sgroi, Birgitta Holmlund, Lambert Skoog, Tommy� Fornander, Bo Nordenskjöld, Olle Stål
Udgivet 2011Artigo -
17
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades af Laura J. Esserman, Christina Yau, Carlie K. Thompson, Laura van ‘t Veer, Alexander D. Borowsky, Katherine A. Hoadley, Nicholas P. Tobin, Bo Nordenskjöld, Tommy� Fornander, Olle Stål, Christopher C. Benz, Linda S. Lindström
Udgivet 2017Artigo -
18
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer af Nancy Yu, Adina Iftimi, Christina Yau, Nicholas P. Tobin, Laura van ‘t Veer, Katherine A. Hoadley, Christopher C. Benz, Bo Nordenskjöld, Tommy Förnander, Olle Stål, Kamila Czene, Laura J. Esserman, Linda S. Lindström
Udgivet 2019Artigo -
19
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study af Sarah Walters, Camille Maringe, J. Butler, Bernard Rachet, Peter Barrett‐Lee, Jonas Bergh, John Boyages, Peer Christiansen, M. Lee, Fredrik Wärnberg, Claudia Allemani, Gerda Engholm, Tommy� Fornander, ML Gjerstorff, Tom Børge Johannesen, Gill Lawrence, C E McGahan, Richard Middleton, John Steward, Elizabeth Tracey, Donna Turner, Martin Richards, Michel P. Coleman
Udgivet 2013Artigo -
20
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer af Linda S. Lindström, Christina Yau, Kamila Czene, Carlie K. Thompson, Katherine A. Hoadley, Laura J. vanʼt Veer, Ronald Balassanian, John W. Bishop, Philip M. Carpenter, Yunn‐Yi Chen, Brian Datnow, Farnaz Hasteh, Gregor Krings, Fritz Lin, Yanhong Zhang, Bo Nordenskjöld, Olle Stål, Christopher C. Benz, Tommy� Fornander, Alexander D. Borowsky, Laura J. Esserman
Udgivet 2017Artigo
Søgeredskaber:
Relaterede emner
Breast cancer
Cancer
Internal medicine
Medicine
Oncology
Tamoxifen
Biology
Confidence interval
Hazard ratio
Gynecology
Paleontology
Stage (stratigraphy)
Cancer research
Estrogen receptor
Randomized controlled trial
Adjuvant
Endocrinology
Mastectomy
Proportional hazards model
Radiation therapy
Adjuvant therapy
Antiestrogen
Biochemistry
Cohort
Environmental health
Estrogen
Goserelin
Hormonal therapy
Hormone
Hormone therapy